LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical device company, today announced preliminary unaudited fourth quarter 2016 net sales of approximately $109 million. These preliminary results represent reported sales growth of 3.7% and constant currency sales growth of 4.2% over the fourth quarter 2015. For the full year 2016, preliminary unaudited net sales were approximately $410 million, an increase of 3.4% on a reported basis and an increase of 4.0% on a constant currency basis over the full year 2015.
